| 2011 |
| 12-29-11 |
Immunotec mourns the death of Dr. Gustavo Bounous |
| 09-15-11 |
Immunotec Announces closing $3.45M of New Financing |
| 08-02-11 |
Immunotec Appoints Mr. Daniel Audet as Vice-President of Marketing |
| 07-31-11 |
Q3-2011 - Period ended July 31, 2011 and Changes to Board of Directors |
| 07-13-11 |
Immunotec and Nova Southeastern University (NSU) Collaborate on New Autism Study using Immunocal® |
| 06-13-11 |
Important New Research using Immunocal® Shows Promise in Lou Gehrig’s Disease |
| 05-24-11 |
Immunotec Signs Material Contract with Glanbia Nutritionals |
| 04-30-11 |
Q2-2011 - Period Ended April 30, 2011 |
| 03-30-11 |
NSU and Immunotec Start Clinical Trail in Autism (see links below)
News Blaze
Medi Lexicon
Enter Prise Post News |
| 03-25-11 |
Q1-2011 - Period Ended January 31, 2011 |
| 02-21-11 |
Q4-2010 - Year Ended October 31, 2010 |
| 01-24-11 |
Immunotec Welcomes New President |
| 2010 |
| 12-22-10 |
Immunotec mourns passing of Senior VP - Dr. Wulf Dröge, Ph.D. |
| 12-09-10 |
Immunotec CEO to retire at the end of the year |
| 11-12-10 |
Immunotec announces Stock Option Grant |
| 09-17-10 |
Q3-2010 - Period ended July 31, 2010 |
| 09-07-10 |
Immunotec announces changes to Management |
| 08-24-10 |
Immunotec appoints new Executive Chairman of the Board |
| 08-10-10 |
Immunotec mourns passing of Chairman Alex Konigsberg |
| 06-21-10 |
Q2-2010 - Period Ended April 30, 2010 |
| 06-16-10 |
Immunotec to Present at the World Cancer Congress Conference In Singapore |
| 05-03-10 |
Immunotec Acquires Assets from Licensee in Mexico and Expands its Seamless Network |
| 05-03-10 |
Immunotec Appoints Robert M. Henry as New Director |
| 03-26-10 |
Q1-2010 - Period Ended January 31, 2010 |
| 02-17-10 |
Q4-2009 - Year Ended October 31, 2009 |
| 2009 |
| 12-07-09 |
Immunotec Announces commencement of IMN 1207 US Lung Cancer Study funded by Moffitt Cancer Center CCOP Research Base |
| 10-01-09 |
Immunotec appoints Patrick Montpetit as Chief Financial Officer |
| 09-29-09 |
Q3-2009 - Period Ended July 31, 2009 |
| 08-03-09 |
Immunotec Announces an Independent, Clinical Research Initiative at Beaumont Hospital’s Community Clinical Oncology Program (CCOP) |
| 07-31-09 |
Immunotec Inc. announces the closing of its Korean operations |
| 07-06-09 |
IMMUNOTEC announces important clinical research initiative: New study to be launched with the goal of improving the quality of the aging process. |
| 06-23-09 |
Q2-2009 - Period Ended April 30, 2009 |
| 03-30-09 |
Election of New Director |
| 03-25-09 |
Q1-2009 - Period Ended January 31, 2009 |
| 02-12-09 |
Q4-2008 - Year Ended October 31, 2008 |
| 2008 |
| 10-23-08 |
Immunotec congratulates 2008 Nobel Prize Winner in Medicine,
Dr. Luc Montagnier |
| 09-24-08 |
Q3-2008 - Period Ended July 31, 2008 |
| 08-28-08 |
Oral Tolerability of Cysteine-Rich Protein Isolate (Immunocal®) in Autism – A Pilot Study |
| 07-03-08 |
Immunotec Inc. Announces New Chief Operating Officer |
| 06-19-08 |
Q2-2008 - Period Ended April 30, 2008 |
| 04-18-08 |
Testing Shows Athletes Can Safely Benefit from Immunocal® |
| 03-28-08 |
Q1-2008 - Period Ended January 31, 2008 |
| 02-19-08 |
Q4-2007 - Year Ended October 31, 2007 |
| 01-17-08 |
Cysteine-Rich Protein Prevents Weight Loss in Lung Cancer Patients: A Promising Intervention Study |
(0 items)
